Full Text
The Impact of Biosimilar Launch on Molecule Price and Pharmaceutical Expense- The Case of the Insulin Glargine in Italy

Abstract

Authors

A Tettamanti L Cioni C Tucci

Back to Volume 20, Issue 9
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×